The post Dogecoin, Shiba Inu, and Pepe Coin Price Prediction as Bitcoin Crashes Below $70K. appeared on BitcoinEthereumNews.com. Dogecoin, Shiba Inu, and Pepe CoinThe post Dogecoin, Shiba Inu, and Pepe Coin Price Prediction as Bitcoin Crashes Below $70K. appeared on BitcoinEthereumNews.com. Dogecoin, Shiba Inu, and Pepe Coin

Dogecoin, Shiba Inu, and Pepe Coin Price Prediction as Bitcoin Crashes Below $70K.

Dogecoin, Shiba Inu, and Pepe Coin prices dropped sharply as Bitcoin plunged beneath the $70,000 threshold. The meme coin market cap dropped to $33.5 billion, with a 10.7% decline within the 24 hours. The Dogecoin fell below $0.10 as it continued to face bearish price action. Shiba Inu price fell by 8%, and Pepe Coin fell by 17% over the past week.

This is a selloff in line with other overall crypto market losses, which fell 8.13% to $2.3 trillion. 

The decrease is due to macroeconomic issues, putting the losses of almost $2 trillion in the hands of Bitcoin since the all-time high in October. Bitcoin is currently back to price levels that it has not experienced since its high in 2021.

Dogecoin Price Dips Below $0.10 Amid Bitcoin’s Sell-off

Dogecoin price traded at $0.0949 after breaking below the $0.10 mark, reflecting a broader market downturn. 

The cryptocurrency closely followed Bitcoin’s 8.16% drop, which triggered over $840 million in liquidations across the crypto market. The market-wide risk-off move has propelled Dogecoin to a very critical state, where it is testing the $0.10 support level.

As the derivatives market weakened, the Open Interest of the futures dropped to 1.06 billion, declining from 1.27 billion. 

Source: Coinglass

Should it be able to maintain above the $0.09 price, there is a possibility of a recovery. Nonetheless, any long-term break above $0.10 would indicate a possible reversal of the trend.

Shiba Inu Price Drops 9%: Key Support Level in Focus

Shiba Inu price has dropped by 9.30%, now standing at $0.00000592 over the past 24 hours. The burn rate is also reduced by 19.50%, and 1,453,488 $SHIB is burnt. The major support level that SHIB is testing is at the moment of $0.0000063.

The burn rate is also reduced by 19.50%, and 1,453,488 $SHIB is burnt. The major support level that SHIB is testing is at the moment of $0.0000063.

If the future Shiba Inu price outlook manages to hold above this, a potential rebound toward $0.0000069 is possible. Nevertheless, a drop below it may indicate a further fall to the subsequent support area, as the overall crypto market fails.

Pepe Coin Faces Key Support Test After Steep Selloff

Pepe coin price dropped by 10% to $0.00000365 over the past 24 hours. The Meme coin is now consolidating around a major resistance level, making several unsuccessful attempts to rise higher.

The price is still under pressure and is developing a potential triangle pattern, despite various efforts. Pepe has fallen by 41% in the last one month and is now close to annual lows.

The coin is corrective after a two-week sharp sell-off. In case Bitcoin gets support around $66,000, Pepe might make an effort to rebound against $0.000004. Nevertheless, a further decrease may challenge the new low of the $0.0000035.

What Next for Dogecoin, Shiba Inu, and Pepe Coin Price?

The future of Dogecoin, Shiba Inu, and Pepe Coin prices is conditioned by the development of the market and the performance of Bitcoin. In case Bitcoin price stabilizes, these top meme coins can rebound, and the additional drops can challenge their support rates.

Source: https://coingape.com/markets/dogecoin-shiba-inu-and-pepe-coin-price-prediction-as-bitcoin-crashes-below-70k/

Market Opportunity
Pepe Logo
Pepe Price(PEPE)
$0.000003668
$0.000003668$0.000003668
-2.70%
USD
Pepe (PEPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26